Related Experiment Videos
Immunoglobulin therapy in infectious disease.
1Department of Medicine, University of California, School of Medicine, San Francisco.
Cleveland Clinic Journal of Medicine
|July 1, 1991
Summary
Intravenous immunoglobulin therapy offers expanded options for preventing and treating infections in vulnerable populations. Future research focuses on combining antibodies with antibiotics and developing targeted monoclonal antibodies for sepsis and inflammatory conditions.
Area of Science:
- Immunology
- Infectious Diseases
- Therapeutics
Background:
- Intravenous immunoglobulin (IVIG) therapy has advanced significantly, expanding its role in managing infectious diseases.
- Specific patient groups like neonates, individuals with AIDS, and bone marrow transplant recipients benefit from these therapeutic improvements.
Purpose of the Study:
- To review the expanded applications of immunoglobulin therapy in infectious disease prevention and treatment.
- To explore future directions in antibody-based therapies, including synergistic approaches and targeted treatments.
Main Methods:
- Review of current literature on immunoglobulin therapy.
- Analysis of advancements in intravenous immunoglobulin (IVIG) administration.
- Discussion of emerging antibody-based therapeutic strategies.
Main Results:
- IVIG therapy is increasingly beneficial for neonates, AIDS patients, and bone marrow transplant recipients.
- Synergistic effects of combining antibiotics with antibodies show promise for future treatments.
- Development of monoclonal antibodies for sepsis and anti-mediator therapies is a key future direction.
Conclusions:
- Intravenous immunoglobulin therapy represents a major advancement in managing infectious diseases, particularly in immunocompromised individuals.
- Future therapeutic strategies will likely involve combination therapies and highly specific monoclonal antibodies targeting pathogens and inflammatory mediators.